Nebius Shares Ride AI Factory Approval to 12.65% Surge Then Retreat as Volume Ranks 168th
Market Snapshot
Nebius Group (NASDAQ: NBIS) closed on March 5, 2026, with a 2.18% decline, following a 12.65% surge on March 3 amid the approval of its 1.2 GW AI factory in Independence, Missouri. Trading volume for the stock dropped 32.69% to $830 million, ranking it 168th in daily trading activity. The stock’s recent volatility reflects a break from a four-day losing streak, as investors initially reacted positively to the project approval but faced subsequent profit-taking or market corrections.
Key Drivers
The approval of Nebius’s 1.2 GW AI factory in Missouri marked a pivotal development for the company, catalyzing a sharp 12.65% rally on March 3. The project, spanning 400 acres, includes a closed-loop cooling system, noise-reduction technology, and a 20-year tax incentive package (PILOT) projected to deliver $650 million to the city and local jurisdictions. The factory is expected to generate 1,200 construction jobs and 130 permanent high-tech roles, aligning with the company’s strategic pivot to AI infrastructure. CEO Arkady Volozh emphasized the project’s significance as the firm’s largest U.S. facility and a blueprint for future expansions, signaling long-term growth ambitions.
The project’s environmental and community benefits further bolstered investor confidence. NebiusNBIS-2.18% committed to STEM and AI literacy programs, workforce development, and a Community Engagement Panel to maintain transparency with residents. The factory’s design, which avoids increasing residential power rates and minimizes water consumption, addresses local concerns about infrastructure strain and environmental impact. These commitments may enhance the company’s reputation as a responsible corporate citizen, potentially attracting ESG-focused investors.
However, the stock’s 2.18% decline on March 5 suggests market caution. The drop in trading volume (to 0.83 billion shares) indicates reduced short-term momentum, possibly due to profit-taking after the initial surge. Analysts highlighted the stock’s high valuation metrics, including a price-to-sales ratio of 41x and a beta of 4.02, which reflect its speculative nature. While the project’s scale and strategic importance are clear positives, investors may be weighing the risks of construction delays, competitive pressures, and the company’s current unprofitability.
The broader AI infrastructure sector remains a key growth driver for Nebius. As demand for AI processing intensifies, the company’s gigawatt-scale projects position it to capitalize on the “infrastructure bottleneck” highlighted in industry reports. The Missouri factory’s 1.2 GW capacity—a level comparable to powering a large city—addresses a critical constraint in AI development, where access to reliable, large-scale energy is increasingly scarce. This infrastructure advantage could solidify Nebius’s role as a key enabler for AI startups and enterprises.
In contrast to short-term price fluctuations, the project represents a long-term bet on AI’s transformative potential. Nebius’s focus on expanding its U.S. footprint, including additional sites in New Jersey, Minnesota, Oklahoma, and Alabama, underscores its commitment to scaling AI infrastructure. The company’s revenue guidance of $3 billion–$3.4 billion for 2026, with a target of $7 billion–$9 billion by year-end, reflects its aggressive growth trajectory. Yet, the path to profitability remains uncertain, with adjusted losses widening in 2025 despite a 479% revenue surge.
Ultimately, the Missouri factory approval validated Nebius’s strategic shift to AI infrastructure, but the stock’s recent performance highlights the market’s balancing act between optimism for future growth and skepticism about execution risks. As the company moves forward with construction, stakeholders will closely monitor progress against timelines, cost overruns, and the broader AI sector’s competitive landscape to assess the project’s long-term impact.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3 Factors That Make TSLA a Risky Choice and One Alternative Stock to Consider

Dycom Skids 4.4% Despite Record Revenue Ranks 469th in $300M Turnover
Hims & Hers Health Tumbles 3.47% as Analyst Downgrades and Legal Risks Sink $300M Volume to 460th Rank
Carpenter Tech's 4.16% Plunge Despite $310M Volume Surge—Stock Ranks 453rd in Activity
